• Study on Briquilimab for Adults with Chronic Inducible Urticaria Unresponsive to H1-Antihistamines

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Germany
  • Study of RVU120 for Patients with Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia

    Not recruiting

    2 1 1 1
    France Italy Poland Spain
  • Study on Ponatinib for Patients with Chronic Myelogenous Leukemia in Molecular Response

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain
  • Study on the Effects of EP262 for Adults with Chronic Spontaneous Urticaria

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany The Netherlands Poland Spain
  • Study of Pembrolizumab with Drug Combination for Patients with Advanced Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Hungary Italy Poland Spain
  • Study on Pembrolizumab and Lenvatinib for Patients with Pre-Treated Thymic Carcinoma and B3-Thymoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Italy Spain
  • Study of Pembrolizumab and Enzalutamide in Patients with Metastatic Hormone-Sensitive Prostate Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    Denmark Ireland Poland
  • Study of Pembrolizumab, Cisplatin, and Gemcitabine for Patients with Muscle-Invasive Bladder Cancer Eligible for Cisplatin Treatment

    Not recruiting

    3 1 1
    Belgium Denmark France Germany Hungary Ireland +4
  • Study on Nicotine Freshmint Mouthspray for E-cigarette Users Looking to Quit

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany
  • Study Comparing Venetoclax and Dexamethasone with Pomalidomide and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Czechia Denmark France Germany Greece Italy +1

powered by